Ann: Positive preclinical data for deoxymabs in vasculitis, page-56

Well you seem to have a convincing argument for selling out before it all falls to pieces and cut your loses.

What is your reason for continuing to hold given the expiry date of the main patent has been known by everyone for many year, many years on top of which:

1. You have lost confidence in Dr. Campbell.

2. You believe the whole process of bringing this to market should have happened years ago.

3. You do not allow for any complexity at all in crossing the Blood Brain Barrier extending timelines.

My opinion only DYOR

Fact Finder